Oral Cancer News | Tag Archive

PMI Labs lowers price of oral cancer brush biopsy test

Saturday, October 23, 2010

Source: www.marketwire.com/ Author: press release PMI Labs is excited to announce that the price of OralAdvance™, the Company’s innovative test designed to detect early stage oral cancer, is lowered by 35% as a result of the completion of the next generation quantitative cytology analysis platform, ClearCyte™. The redesigned and reengineered ClearCyte™ platform allows for faster [...]

Lilly presents new data in head and neck cancer – a difficult to treat cancer with poor survival rates

Wednesday, October 13, 2010

0 Comments

Source: www.prnewswire.com Author: press release Eli Lilly and Company announced today that its global Phase III trial evaluating Alimta® (pemetrexed for injection) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (SCCHN) did not meet its primary endpoint for overall survival. Data were presented for the [...]

ASCO: Second study links HPV to mouth cancer outcomes

Monday, June 7, 2010

0 Comments

Source: www.medpagetoday.com/ Author: Michael Smith, North American Correspondent, MedPage Today Human papillomavirus (HPV) infection predicts a better chance of survival in patients with oropharyngeal squamous cell carcinoma, researchers said. In a retrospective analysis of a major radiation therapy trial, more than four-fifths of patients whose tumors were HPV-positive were alive three years after treatment, according [...]

No need to fear!

Monday, May 31, 2010

0 Comments

Source: www.healthcanal.com Author: staff Patients with dental phobias will now be able to relax in the dentist’s chair, as new brain calming technology can help de–stress those with even the worst fears. New equipment developed by neuroscientists in America is being introduced in dental surgeries in the UK to help calm patients who suffer anxiety [...]

Enzyme predictive of head and neck cancer survival

Tuesday, April 20, 2010

0 Comments

Source: www.insidermedicine.ca Author: staff Scientists have identified an enzyme that may predict survival from head and neck cancer, according to a report presented at the annual meeting of the American Association for Cancer Research. Researchers analyzed tissue samples from over 100 squamous carcinoma patients, finding that those with low levels of the enzyme ERCC1 had [...]

Genmab to review clinical plans for head and neck cancer candidate after mixed results from phase III trial

Sunday, April 18, 2010

0 Comments

Source: www.genengnews.com Author: staff Genmab is reporting that Phase III results of its antibody for head and neck cancer, zalutumumab, showed that the treatment did not increase overall survival enough for it to be statistically significant but did significantly boost progression-free survival. The company says that it is evaluating its development program in this indication [...]

Adjuvant radiotherapy helpful in early, node-positive oral cancer

Monday, March 29, 2010

0 Comments

Source: www.acr.org Author: David Douglas Postoperative radiotherapy significantly improves survival in patients with early T stage oral cavity squamous cell carcinoma and a single positive lymph node, researchers report in the March issue of Archives of Otolaryngology: Head and Neck Surgery. “Even for small primary tumors of the oral cavity, the presence of a single [...]

Metabolic activity of head and neck cancer may help guide treatment

Thursday, March 18, 2010

0 Comments

Source: www.oncologystat.com Author: Staff The metabolic activity of head and neck squamous cell carcinoma on pretreatment imaging independently predicts outcomes in patients who undergo intensity-modulated radiation therapy, new data show. This imaging information can be used to tailor treatment, especially to reduce the risk of distant metastases, lead investigator Dr. Min Yao said at a [...]

Oropharyngeal cancer, human papilloma virus, and clinical trials

Wednesday, December 30, 2009

0 Comments

Source: Journal of Clinical Oncology, Vol 28, No 1 (January 1), 2010: pp. 1-3 Author: Danny Rischin As advances in our understanding of the molecular biology of cancer have evolved in recent years, cancers that were once considered to be relatively homogeneous diseases are now being recognized as comprising distinct subtypes. These subtypes may differ [...]

A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma

Saturday, November 28, 2009

1 Comment

Source: Arch Otolaryngol Head Neck Surg, November 1, 2009; 135(11) Authors: JJ Jaber et al. Objective: To determine the recurrence and survival outcome based on treatment date, type of treatment, stage of disease, and comorbidity and the recurrence and survival differences based on smoking status as a surrogate for human papillomavirus status in veterans treated [...]

Tag Archive | "survival"